Stanozolol 25 - Generica

Initially produced in tablet form, Stanozolol later expanded into injectable use, particularly in veterinary contexts. Marketed as Winstrol since 1962, it was developed by Winthrop and widely adopted for treating wasting disorders and bone conditions. Its DHT-based design and pyrazole substitution created an anabolic agent with reduced androgenic and zero estrogenic activity. Though removed from American pharmaceutical lists, it continues to be sold abroad, often in animal care. It remains a notable exception among DHT derivatives for its oral effectiveness.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Stanozolol 25 by Generica, consult with your doctor or healthcare professional.